What is Disc Medicine's short- term investments?

Disc Medicine (IRON) reported short- term investments of $641.25M in Q1 2026.

How has Disc Medicine's short- term investments changed year-over-year?

Disc Medicine's short- term investments increased by 12.1% year-over-year, from $571.99M to $641.25M.

Disc Medicine IRON Short- term Investments

Short- term Investments at other companies

Vertex PharmaceuticalsVRTX

——

Protagonist TherapeuticsPTGX

——

Beam TherapeuticsBEAM

——

PTC TherapeuticsPTCT

——

Other financials

Income statement

See full

Operating income-$69.5M-74.0%

Net income-$63.5M-86.3%

EPS (diluted)-$1.65-61.8%

Balance sheet

See full

Cash & equivalents$88.9M-27.5%

Total debt$31.1M+1.4%

Total equity$688.4M+4.3%

Total assets$750.2M+5.8%

Cash flow

See full

Operating cash flow-$62.2M-50.4%

CapEx--100%

Free cash flow-$62.2M-47.4%

Valuation

See full

Market cap$2.69B+42.2%

Enterprise value$2.63B+46.7%

Returns & leverage

See full

Return on equity-35.8%+41.3pp

Debt / equity0×0.0×

Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Disc Medicine's short- term investments?: Disc Medicine (IRON) reported short- term investments of $641.25M in Q1 2026.
How has Disc Medicine's short- term investments changed year-over-year?: Disc Medicine's short- term investments increased by 12.1% year-over-year, from $571.99M to $641.25M.